Stocks and Investing Stocks and Investing
Wed, November 8, 2017
Tue, November 7, 2017

Michael Schmidt Maintained (ABUS) at Hold with Increased Target to $5.5 on, Nov 7th, 2017


Published on 2024-10-26 00:41:07 - WOPRAI, Michael Schmidt
  Print publication without navigation


Michael Schmidt of Leerink Swann, Maintained "Arbutus Biopharma Corporation" (ABUS) at Hold with Increased Target from $4 to $5.5 on, Nov 7th, 2017.

Michael, nor any peers, have made any analyst calls on ABUS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources